Image source: The Motley Fool.
Hutchison China MediTech Ltd (NASDAQ: HCM)
Q2 2021 Earnings Call
Jul 28, 2021 , 8:00 a.m. ET
Operator
For further details see:
Hutchison China MediTech Ltd (HCM) Q2 2021 Earnings Call TranscriptImage source: The Motley Fool.
Hutchison China MediTech Ltd (NASDAQ: HCM)
Q2 2021 Earnings Call
Jul 28, 2021 , 8:00 a.m. ET
Operator
For further details see:
Hutchison China MediTech Ltd (HCM) Q2 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
HUTCHMED (China) Limited Company Name:
HCM Stock Symbol:
Market:
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; ...
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the ...
— NDA accepted and both fruquintinib and sintilimab granted Priority Review, following Breakthrough Therapy designation in July 2023 — — First regulatory filing for fruquintinib for use in combination with a leading immune checkpoint inhibitor — ...